Drug Discovery Today Magazine
486 FOLLOWERS
Drug Discovery Today is a review journal, that covers the whole of the preclinical drug discovery process, from target identification and validation, through hit identification, lead identification, and optimization, through to candidate selection. The reviews are at the cutting edge of the science underpinning drug discovery, written by experts in their respective fields.
Drug Discovery Today Magazine
3w ago
In July 2022 the SMR hosted a conference on ‘Innovative new pharma and biotech partnerships: How is the landscape transforming?’ That conference looked at ongoing developments in pharmaceutical discovery and development, focused on the need for partnerships between large pharmaceutical and new biotech companies to tackle the next generation therapeutic challenges ..read more
Drug Discovery Today Magazine
3M ago
Researchers from the Royal Veterinary College (RVC) and University of Oxford have led an innovative project investigating the progression of malaria infection and the role of the parasite to better aid the development of an effective malaria vaccine and significantly reduce rates of deaths from the disease ..read more
Drug Discovery Today Magazine
4M ago
A team led by Research Professor Gintautas Tamulaitis from Vilnius University Life Sciences Center (VU LSC) revealed a novel protection mechanism in CRISPR-Cas antiviral defense system. The article “Ribosomal stalk-captured CARF-RelE ribonuclease inhibits translation following CRISPR signaling” was published in the journal Science ..read more
Drug Discovery Today Magazine
4M ago
Researchers have established a first potential therapeutic target for a type of early-onset dementia ..read more
Drug Discovery Today Magazine
4M ago
DPV has plans to further expand the fund up to £25m in the next three years with a focus on companies developing novel and disruptive technologies that have strong collaborative relationships with Discovery Park ..read more
Drug Discovery Today Magazine
4M ago
• BugBiome wins a business support package worth over £100,000, including one year of free lab space at Discovery Park and £50,000 investment from Discovery Park Ventures• BioMavericks awarded the wildcard prize as voted for by the audience at the GIANT Health Healthcare Investment Show on 5th December ..read more
Drug Discovery Today Magazine
5M ago
Cancer Research UK, and the KWF Dutch Cancer Society (KWF), two of the world’s largest charitable funders of cancer research, announce a new multi-project strategic partnership to advance promising therapeutic agents for cancer through early clinical development ..read more
Drug Discovery Today Magazine
5M ago
Researchers have built the first ever map showing how every single neuron in the nervous system of a tiny worm communicates wirelessly ..read more
Drug Discovery Today Magazine
5M ago
The trial showed that KT-110 has superior efficacy in reducing alcohol consumption. KT-110 will be deliverable in a once-daily tablet (proprietary formulation). KT-110’s mode of action is novel to Alcohol Use Disorder (AUD) and works by simultaneously modulating the noradrenergic and serotonergic brain receptors that counteract the neurobiological processes involved in addictionAlcohol dependence, or AUD, is a serious public health issue and the medical need for the treatment of alcoholism is considerable and unmet. Kinnov Therapeutics expects to have clear guidance from the FDA in early 2024 ..read more
Drug Discovery Today - Latest News
5M ago
Bio-IT World Conference & Expo to Foster Collaboration Among Life Sciences, IT and Healthcare Leaders Who are Redefining Precision Medicine ..read more